Expression of the immune checkpoint molecules PD‑L1 and PD‑1 in EBV‑associated lymphoproliferative disorders: A meta‑analysis
Authors:
Open Access
- 10 November 2023
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 27 (1) , 1-10
Abstract
Epstein‑Barr virus (EBV) has been implicated in the development of a wide range of lymphoproliferative disorders. In this process, the role of programmed cell death 1 (PD‑1)/programmed cell death ligand 1 (PD‑L1) has remained to be clarified. A meta‑analysis of 20 studies was performed and risk ratios (RRs) with 95% confidence intervals (CIs) were used to evaluate the association between PD‑L1/PD‑1 expression and the status of EBV infection. The results showed that the expression level of PD‑L1 in tumor cells was significantly higher in EBV+ cases with a pooled RR of 2.26 (95% CI, 1.63‑3.14; P<0.01), particularly in subtypes of diffuse large B‑cell lymphoma (DLBCL) and classical Hodgkin lymphoma. Similarly, EBV infection increased the expression of PD‑L1 in immune cells with a pooled RR of 2.20 (95% CI, 1.55‑3.12; P0.05). The present meta‑analysis demonstrated that in EBV‑associated lymphoproliferative disorders, EBV infection was associated with the expression level of PD‑L1 in tumor cells and immune cells but was not associated with the expression of PD‑1 in TILs.Keywords
This publication has 48 references indexed in Scilit:
- PD-1–Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck CancerCancer Research, 2013
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerNew England Journal of Medicine, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted TherapyClinical Cancer Research, 2012
- EBV-associated lymphomas in adultsBest Practice & Research Clinical Haematology, 2012
- Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinomaWorld Journal of Gastroenterology, 2011
- The PD‐1 pathway in tolerance and autoimmunityImmunological Reviews, 2010
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cellsJournal of Experimental Medicine, 2009
- EBV-Associated Lymphoproliferative Disorders: Classification and TreatmentThe Oncologist, 2008
- Epstein–Barr virus and oncogenesis: from latent genes to tumoursOncogene, 2003